Skip to main content
. 2010 Jun 21;8:37. doi: 10.1186/1741-7015-8-37

Table 4.

Effect on pain and quality-of-life of agents used to treat herpes zoster (HZ) and/or post-herpetic neuralgia (PHN)

Treatment Advantages Disadvantages
Antiviral agents Relieve acute HZ pain and accelerate lesion healing if administered within 72 h of acute-symptom onset [8].
Few adverse effects [75,76].
May slightly reduce PHN symptoms and their duration [5,8,60,67,71,77-79].
Administration within 72 h is usually not achievable [8].
In clinical trials, 20%-30% of treated patients still develop PHN [37,71].

Corticosteroids Reduce intensity of pain and overall duration of the acute phase [37,80,81].
Significantly accelerate time to uninterrupted sleep, return to daily activity, and cessation of analgesic therapy.
Do not prevent PHN and produce significant adverse events in older adults; their routine use is therefore not recommended in elderly patients with HZ [37].

Simple analgesics May reduce pain in HZ and PHN [11,75]. Few trials assessing efficacy in HZ or PHN.

Tricyclic antidepressants Provide effective pain relief in PHN patients (numbers needed to treat = 2.8) and may possibly provide benefits through sedative actions given that PHN can induce sleep disturbances and anxiety [67]. Side-effects may cause further QoL problems.
Patients do not regain the level of life-satisfaction that they had before PHN developed [43,67].

Antiepileptics Gabapentin and pregabalin offer reasonable relief for PHN [82-84]. Levels of pain relief are not associated with similar improvements in QoL scores [82-84].

Opioids Maximum tolerable doses may reduce PHN pain [67]. Side-effects are common and troublesome, particularly for elderly patients; overall benefits are therefore limited [67].

Topical agents Lidocaine patch provides some pain relief and has few side-effects [85].
Capsaicin dermal patch significantly reduces pain [86].
Discomfort experienced with capsaicin formulations; overall benefits are therefore limited [11].
Pain relief with capsaicin dermal patch is not associated with improved QoL in PHN [86].

Epidural therapies and nerve blocks Continuous epidural local anaesthetic has been shown to effectively treat acute-phase HZ pain [87].
Prolonged (not single-dose or short-term) epidural local anaesthetic blockade with corticosteroid may provide some protection against PHN [88].
Single-dose epidural local anaesthetic/steroid does not prevent PHN [89].
Epidural corticosteroid has potential risk, and anecdotal evidence has not supported the benefit.
Prolonged epidural local anaesthetic blockade is not practical for widespread use and carries some risk [88].